S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
SHOCKING Crypto Leak… (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
SHOCKING Crypto Leak… (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
SHOCKING Crypto Leak… (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
SHOCKING Crypto Leak… (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
ASX:EX1

Exopharm (EX1) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free EX1 Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Exopharm

Exopharm Limited develops transformative medicines based upon exosomes or extracellular vesicles (EVs) in Australia. The company's technology includes LOAD technology platform that enables loading of active pharmaceutical ingredient (API) into exosomes; Ligand-based Exosome Affinity Purification (LEAP) technology that solves the critical bottleneck of exosome isolation and purification; MASTER CELL BANK to manufacture clinical-grade engineered exosomes; EVPS technology platform that allows specific molecules to be attached to the surface of exosomes to target them to selected tissues, organs, or cell types; EXORIA, a novel and proprietary dye that tags invisible exosomes to enhance tracking in experimental studies and laboratory analysis; and FORMULATION H to enable the stable storage and transport of exosome medicines. Exopharm Limited has research collaboration agreements with Astellas Institute for Regenerative Medicine. The company was incorporated in 2013 and is based in Camberwell, Australia.

EX1 Stock News Headlines

November 20, 2023 | bbc.com
EX1 - Weather warnings issued
November 18, 2023 | finance.yahoo.com
Exopharm Limited (EX1.XA)
April 19, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
August 30, 2023 | finance.yahoo.com
Exopharm Full Year 2023 Earnings: AU$0.036 loss per share (vs AU$0.064 loss in FY 2022)
May 22, 2023 | finance.yahoo.com
One Exopharm Insider Raised Their Stake In The Previous Year
December 2, 2022 | finance.yahoo.com
Exopharm Limited (ASX:EX1) insider upped their holding by 15% earlier this year
August 27, 2022 | finance.yahoo.com
Exopharm Limited (EX1.AX)
June 22, 2022 | finance.yahoo.com
Exopharm Limited (ASX:EX1) up 14%, but insiders are still down 49% after purchasing AU$895k of stock last year
April 19, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
May 11, 2022 | finance.yahoo.com
Is Exopharm (ASX:EX1) In A Good Position To Deliver On Growth Plans?
See More Headlines
Receive EX1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exopharm and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:EX1
CUSIP
N/A
CIK
N/A
Web
www.exopharm.com
Phone
61 3 9111 0026
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,320,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-121.54%
Return on Assets
-51.37%

Debt

Debt-to-Equity Ratio
37.16
Current Ratio
7.82
Quick Ratio
2.03

Sales & Book Value

Annual Sales
$1.18 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.39
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
439,420,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.26
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Ian E. Dixon M.A.I.C.D.
    M.B.A., MBA, Ph.D., Founder, Technology Co-Founder, CEO MD & Director
  • Dr. Gregor Lichtfuss M.Sc.
    Co-Founder & Business Services Manager
  • Mr. Johannes Muhl
    Senior Vice President of Finance
  • Mr. David James Franks BEc (Age 54)
    C.A., F Fin, J.P., Company Secretary

Key Competitors

View All Competitors

Insiders


This page (ASX:EX1) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends